Oragenics Inc/ US6840235005 /
2024-07-26 9:59:52 PM | Chg. +0.06 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
1.06USD | +5.50% | 1,577 Turnover: 1,657.26 |
-Bid Size: - | -Ask Size: - | 1.06 | 1.02 |
GlobeNewswire
05-16
Oragenics, Inc. Prepares Intranasal Pharmaceutical, ONP-002, for Phase II Concussion Trial
GlobeNewswire
05-07
Oragenics Partners with Avance Clinical for Phase II Concussion Trial in Australia
GlobeNewswire
2020-09-01
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2020 and Recent Developm...
GlobeNewswire
2020-07-14
Recce Pharmaceuticals Adds Biotech Veteran Alan W. Dunton M.D. to its Board of Directors
GlobeNewswire
2019-04-30
Investor Expectations to Drive Momentum within H&R Block, Aercap Holdings N.V, Oragenics, and Atomer...
GlobeNewswire
2018-06-20
Diamond Equity Research Initiates Coverage on Oragenics Inc. (NYSE:OGEN) with a Valuation of $3.50 P...